MX2016012697A - Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales. - Google Patents

Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales.

Info

Publication number
MX2016012697A
MX2016012697A MX2016012697A MX2016012697A MX2016012697A MX 2016012697 A MX2016012697 A MX 2016012697A MX 2016012697 A MX2016012697 A MX 2016012697A MX 2016012697 A MX2016012697 A MX 2016012697A MX 2016012697 A MX2016012697 A MX 2016012697A
Authority
MX
Mexico
Prior art keywords
protein biomarker
colorectal tumors
biomarker profiles
detecting colorectal
disclosed
Prior art date
Application number
MX2016012697A
Other languages
English (en)
Inventor
John Blume
Ryan Benz
Lisa Croner
Roslyn Dillon
Jeffrey Jones
Heather Skor
Bruce Wilcox
Kao Athit
Preston Richard
Original Assignee
Applied Proteomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Proteomics Inc filed Critical Applied Proteomics Inc
Publication of MX2016012697A publication Critical patent/MX2016012697A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Se describen en la presente paneles relacionados con el diagnóstico o reconocimiento de cáncer de colon y colorrectal en un sujeto. Los paneles y métodos relacionados descritos son usados para predecir o evaluar el estado del cáncer de colon en un paciente. Ellos pueden ser usados para determinar la naturaleza del tumor, la recurrencia, o la respuesta del paciente a los tratamientos. Algunas modalidades de los métodos incluyen la generación de un reporte para el manejo clínico.
MX2016012697A 2014-03-28 2015-03-27 Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales. MX2016012697A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201461972153P 2014-03-28 2014-03-28
US201462005835P 2014-05-30 2014-05-30
US201562107265P 2015-01-23 2015-01-23
PCT/US2015/023187 WO2015149030A1 (en) 2014-03-28 2015-03-27 Protein biomarker profiles for detecting colorectal tumors

Publications (1)

Publication Number Publication Date
MX2016012697A true MX2016012697A (es) 2017-05-09

Family

ID=54196479

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016012697A MX2016012697A (es) 2014-03-28 2015-03-27 Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales.

Country Status (10)

Country Link
US (1) US20170176441A1 (es)
EP (1) EP3123171A4 (es)
JP (1) JP2017520775A (es)
CN (1) CN106461647A (es)
AU (1) AU2015237229A1 (es)
CA (1) CA2943827A1 (es)
IL (1) IL247987A0 (es)
MX (1) MX2016012697A (es)
SG (1) SG11201608053PA (es)
WO (1) WO2015149030A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9141756B1 (en) 2010-07-20 2015-09-22 University Of Southern California Multi-scale complex systems transdisciplinary analysis of response to therapy
MA44511A (fr) * 2016-03-31 2019-02-06 Discerndx Inc Génération et utilisation de bases de données de biomarqueurs
CN106279403B (zh) * 2016-08-16 2019-06-11 长春市海兰深生物医学技术有限公司 一种检测天然肺癌相关抗体的组合物、试剂盒和方法
US20180100858A1 (en) * 2016-10-07 2018-04-12 Applied Proteomics, Inc. Protein biomarker panels for detecting colorectal cancer and advanced adenoma
CN107505461B (zh) * 2017-08-31 2020-05-08 北京臻惠康生物科技有限公司 一种纤维蛋白原γ链的新用途及试剂盒
EP3676393A4 (en) 2017-09-01 2021-10-13 Venn Biosciences Corporation IDENTIFICATION AND USE OF GLYCOPEPTIDES AS BIOMARKERS FOR DIAGNOSIS AND MONITORING OF TREATMENT
AU2018351147A1 (en) * 2017-10-18 2020-05-07 Venn Biosciences Corporation Identification and use of biological parameters for diagnosis and treatment monitoring
CN109580948B (zh) * 2018-11-30 2021-08-10 中国科学院上海有机化学研究所 基于二氢胸腺嘧啶代谢物的组合在结直肠癌诊断及预后预测中的应用
CN111253492B (zh) * 2018-11-30 2021-10-08 华中科技大学 一种透脑性多肽及其在制备防治老年痴呆药物中应用
CN112501294B (zh) * 2020-12-03 2022-10-04 中山大学 一种结直肠癌生物标志物及其应用
CN112881692B (zh) * 2021-01-08 2022-11-22 深圳华大基因股份有限公司 一种用于结直肠癌及腺瘤早期筛查的蛋白定量检测方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE376674T1 (de) * 2004-08-13 2007-11-15 Indivumed Gmbh Verwendung von transthyretin als biomarker zum nachweis von kolorektalen adenomen; verfahren und nachweis-system
WO2007016367A2 (en) * 2005-07-29 2007-02-08 Bayer Healthcare Llc Neoplastic disease-related methods, kits, systems and databases
EP2412822A1 (en) * 2006-01-11 2012-02-01 Genomic Health, Inc. Gene expression markers for colorectal cancer prognosis
JP2011517765A (ja) * 2007-06-04 2011-06-16 ダイアグノプレックス エセアー 結腸直腸癌のためのバイオマーカの組み合わせ
JP2012517607A (ja) * 2009-02-20 2012-08-02 オンコノム，インコーポレイテッド 大腸癌の診断及び予後判定のための用具セット及び方法
CN103140760B (zh) * 2010-07-14 2016-01-27 联邦科学与工业研究组织 结肠直肠癌的诊断
WO2013152989A2 (en) * 2012-04-10 2013-10-17 Eth Zurich Biomarker assay and uses thereof for diagnosis, therapy selection, and prognosis of cancer
WO2014085826A2 (en) * 2012-11-30 2014-06-05 Applied Proteomics, Inc. Method for evaluation of presence of or risk of colon tumors

Also Published As

Publication number Publication date
CN106461647A (zh) 2017-02-22
EP3123171A4 (en) 2018-01-03
IL247987A0 (en) 2016-11-30
US20170176441A1 (en) 2017-06-22
CA2943827A1 (en) 2015-10-01
EP3123171A1 (en) 2017-02-01
SG11201608053PA (en) 2016-10-28
JP2017520775A (ja) 2017-07-27
AU2015237229A1 (en) 2016-11-10
WO2015149030A1 (en) 2015-10-01

Similar Documents

Publication Publication Date Title
GB2545361A (en) Protein biomarker panels for detecting colorectal cancer and advanced adenoma
MX2016012697A (es) Perfiles de marcadores biologicos de proteina para detectar tumores colorrectales.
MX2017008421A (es) Métodos terapéuticos, diagnósticos y pronósticos para el cáncer de vejiga.
CY1126115T1 (el) Συνδυασμος anti-lag-3 αντισωματων και anti-pd-1 αντισωματων για θεραπεια ογκων
MX2015006757A (es) Método para la evaluación de la presencia de o riesgo de tumores de colon.
EP4219765A3 (en) Prostate cancer prognosis using biomarkers
MY197809A (en) Biomarkers and methods of treating pd-1 and pd-l1 related conditions
MX361058B (es) Método para detectar células tumorales circulantes 5t4-positivas y métodos de diagnóstico de cáncer 5t4-positivo en un sujeto mamífero.
MA39776A (fr) Traitement du cancer avec des antagonistes de c-met et corrélation de ces derniers avec l'expression de hgf
UY36325A (es) Paneles del gen mutante del fgfr para identificar cánceres sensibles al tratamiento con un inhibidor del fgfr
WO2016109782A3 (en) Methods and compositions for detecting colorectal neoplasias
EP3186397C0 (en) USE OF BIOMARKERS OF CIRCULATING CELLS IN THE BLOOD FOR THE DETECTION AND DIAGNOSIS OF DISEASES, AND THEIR ISOLATION PROCESSES
EP3100046A4 (en) Detection of prostate specific membrane antigen (psma) expression on circulating tumor cells (ctc)
MX2018009254A (es) Metodos para evaluar el riesgo de desarrollar cancer colorrectal.
NZ703411A (en) Use of markers in the diagnosis and treatment of prostate cancer
TR201909951T4 (tr) Kanser olduğundan şüphelenilen bir hastanın aflibersept ile tedavisinin sonucunun öngörülmesine yönelik yöntem.
EP4202441A3 (en) Gene expression profile in macrophages for the diagnosis of cancer
MX2016015163A (es) Biomarcadores mit y metodos para su uso.
MA40636A (fr) Procédés pour détecter le cancer de la prostate
WO2015187727A3 (en) Molecular mammography
WO2014107718A3 (en) Heat shock protein (hsp) inhibition and monitoring effectiveness thereof
WO2015181555A8 (en) Expression profiling for determining the responsiveness of cancers to treatment with an anti-angiogenic agent
WO2013132354A3 (en) Gene signatures associated with efficacy of postmastectomy radiotherapy in breast cancer
WO2014143794A3 (en) Diagnostic and prognostic marker for prostate cancer
WO2016018524A8 (en) E2f4 signature for use in diagnosing and treating breast and bladder cancer